The influence of liver cirrhosis, additional probiotics, and alcohol consumption on hepatic fibrosis and the gut microbiota deserves attention
F Du, L Tao - The Journal of Nutrition, 2024 - jn.nutrition.org
We have read with interest the article published by Escouto GS et al [1]. At present,
nonalcoholic steatohepatitis (NASH) has gradually become a research hotpot in the field of …
nonalcoholic steatohepatitis (NASH) has gradually become a research hotpot in the field of …
Probiotic supplementation, hepatic fibrosis, and the microbiota profile in NASH patients: a randomized controlled trial.
GS Escouto, GZ Port, CV Tovo, SA Fernandes… - The Journal of …, 2023 - europepmc.org
Background Promising results in the improvement of nonalcoholic fatty liver disease
(NAFLD) and nonalcoholic steatohepatitis (NASH) have been identified following the …
(NAFLD) and nonalcoholic steatohepatitis (NASH) have been identified following the …
Probiotic supplementation, hepatic fibrosis, and the microbiota profile in patients with nonalcoholic steatohepatitis: a randomized controlled trial
GS Escouto, GZ Port, CV Tovo, SA Fernandes… - The Journal of …, 2023 - Elsevier
Background Promising results in improvement of nonalcoholic fatty liver disease and
nonalcoholic steatohepatitis (NASH) have been identified following probiotic (PRO) …
nonalcoholic steatohepatitis (NASH) have been identified following probiotic (PRO) …
Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
MR Bomhof, JA Parnell, HR Ramay, P Crotty… - European journal of …, 2019 - Springer
Purpose In obesity and diabetes the liver is highly susceptible to abnormal uptake and
storage of fat. In certain individuals hepatic steatosis predisposes to the development of non …
storage of fat. In certain individuals hepatic steatosis predisposes to the development of non …
[HTML][HTML] Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol
AS Silva-Sperb, HA Moraes, BC de Moura, BC Alves… - Trials, 2019 - Springer
Background Recently factors in the relationship between gut microbiota, obesity, diabetes
and the metabolic syndrome have been suggested in the development and progression of …
and the metabolic syndrome have been suggested in the development and progression of …
Assessment of Intestinal Microbiota in Non-Alcoholic Fatty Liver Disease: 101
M Mouzaki, BM Arendt, SE Fischer, EM Comelli… - Hepatology, 2012 - journals.lww.com
Background: The composition of intestinal microbiota (IM) differs between obese and lean
subjects. This may contribute to the pathogenesis of obesity. Although non-alcoholic fatty …
subjects. This may contribute to the pathogenesis of obesity. Although non-alcoholic fatty …
[HTML][HTML] From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose …
diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose …
[PDF][PDF] The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
Several animal studies have emphasized the role of gut microbiota in nonalcoholic fatty liver
disease (NAFLD). However, data about gut dysbiosis in human NAFLD remain scarce in the …
disease (NAFLD). However, data about gut dysbiosis in human NAFLD remain scarce in the …
Design and rationale of the INSYTE study: a randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal …
E Scorletti, PR Afolabi, EA Miles, DE Smith… - Contemporary clinical …, 2018 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of fat-related
conditions ranging from simple fatty liver, to non-alcoholic steatohepatitis (NASH), fibrosis …
conditions ranging from simple fatty liver, to non-alcoholic steatohepatitis (NASH), fibrosis …
[HTML][HTML] Investigation of synbiotic treatment in non-alcoholic fatty liver disease (INSYTE study): a double-blind, randomised, placebo-controlled, phase 2 trial
E Scorletti, PR Afolabi, EA Miles, DE Smith… - …, 2020 - ncbi.nlm.nih.gov
Background Recent evidence suggests that dysbiosis may play a role in the pathogenesis of
non-alcoholic fatty liver disease (NAFLD) and treatment with a synbiotic (a combined …
non-alcoholic fatty liver disease (NAFLD) and treatment with a synbiotic (a combined …